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Abstract
Background: Rare sites of metastases, atypical symptoms and paraneoplastic syndromes are often neglected or
misinterpreted, especially when they represent early symptoms of an underlying malignant disease. Hence, an
interdisciplinary approach to these patients is essential to avoid tumor progression and metastatic spread in order
to provide curative treatment options to the patients. We here report the case of a young woman presenting with
visual loss which led to diagnosis of a thymic carcinoma.
Case presentation: A 28-year old white woman presented with subacute loss of vision in the last trimester of her
first pregnancy which was first interpreted as an exacerbation of a pre-existing dermatomyositis and treated with
steroids. After failure of steroid therapy choroidal metastases from an undifferentiated thymic carcinoma were
diagnosed. This also shed a new light on the dermatomyositis the patient had been suffering from for seven years
possibly representing a paraneoplastic syndrome from the tumor. Despite aggressive chemotherapy, the patient
died from progressive disease eight years after first onset of dermatomyositis and 14 months after initial diagnosis
of the thymic carcinoma.
Conclusions: Choroidal metastases from a thymic carcinoma have never been reported before but should be
included into the differential diagnosis of choroidal masses.
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Background
Primary thymic carcinomas are rare tumors accounting
for 7-25 % of all neoplasms of the thymus [1]. They are
distinguished from the more frequent thymomas based
on their different morphology and biology [2, 3]. Due to
frequent invasion of pericardium or pleural space and
metastatic spread, their prognosis is generally poor [4]
with median survival times for patients with irresectable
disease of 13 months [5]. Thymic carcinomas differ from
thymomas also with respect to associated paraneoplastic
autoimmune diseases. Thymomas are frequently associ-
ated with characteristic autoimmune phenomena like my-
asthenia gravis or pure red cell aplasia, which normally do
not occur in thymic carcinomas. However, sporadic cases
of polymyositis or hypercalcemia have been encountered
in the latter [6–8].
Choroidal metastases are exceedingly rare. They can oc-
casionally cause symptoms leading to the primary diagno-
sis of other tumors like lung and breast cancers, as well as
melanoma [9, 10]. However, in most patients the under-
lying diseases are already diagnosed, and choroidal metas-
tases represent late symptoms of the disease [10].
With the permission of the kin of the patient, we here
report a case in which the presentation with visual loss
resulted in the diagnosis of a thymic carcinoma which
had not been found during earlier examinations.
Case presentation
A 28-year old white woman presented with distinct de-
terioration of visual acuity during the last trimester of
her first pregnancy. Her vision decreased to 20/40 in the
left and 20/400 in the right eye. In the beginning, the
visual loss occurred intermittently, but worsened over
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time. In addition, the patient complained about flickering.
During the worst episodes she could only see contours
with a vague discrimination of light. Simultaneously,
symptoms of a dermatomyositis, which had been diag-
nosed and successfully treated several years earlier, reap-
peared. At that time, the diagnosis of dermatomyositis had
been confirmed by skin biopsy. An extensive workup to
rule out an underlying malignancy had then not revealed
any suspicious results. However, a CT scan had not been
performed. The patient subsequently had received several
immunosuppressive treatments including azathioprine,
methotrexate and adalimumab, as well as immunoglobu-
lins and steroids resulting in a long-lasting remission of
the dermatomyositis.
The decrease in visual acuity occurred isochronal with
another exacerbation of skin symptoms and was there-
fore initially interpreted as a manifestation of the reap-
pearing dermatomyositis and treated with steroids since
also initial ophthalmologic workup did not reveal patho-
logical results. After failure of immunosuppressive ther-
apy, repeated ophthalmologic examination revealed an
amelanotic choroidal mass at the posterior pole includ-
ing the peripapillary region and a second choroidal le-
sion superior to the optic disc in the right eye. Also, in
the left eye another amelanotic choroidal tumor situated
predominantly nasal superior to the optic disc was de-
tected. In both eyes, an inferior exsudative retinal de-
tachment was seen (Fig. 1a and b). Finally, a large tumor
mass in the mediastinum, pleural thickening and pul-
monary nodules as well as a mediastinal lymphadenop-
athy were detected in MRI scans. CT scans were not
performed because of the actual pregnancy. After deliv-
ery of a healthy boy at the 37th + 2 week of pregnancy
through Caesarean section, a lung and pleural biopsy
was performed by lateral thoracotomy and the patient
was referred to our center for further treatment.
The clinical examination showed a 28-year old woman
in proper general condition. Her skin was reddish and
thickened with distinct flaking. The examination of the
heart, lungs and abdomen did not reveal any pathologic
results. Decreased visual acuity was noted in both eyes.
Additionally, the patient complained about paraesthesia
with tickling in both feet. Other neurological symptoms
were not detectable.
Laboratory testing revealed a slightly increased creat-
ine kinase (193 U/l, normal up to 170 U/l), an elevated
C-reactive protein (2.77 mg/dl, normal up to 0.5 mg/dl),
anemia with haemoglobin of 9.8 g/dl, elevated uric acid
levels of 6.5 mg/dl (reference range 2.4 to 5.7 mg/dl)
and a significantly increased lactate dehydrogenase of
959 U/l (normal up to 250 U/l) as well as thrombocyto-
sis of 789 G/μl (normal up to 450 G/μl).
Whole body CT and MRI scans showed metastases to
the choroids, pleura and regional lymph nodes (Fig. 1b
and c). The lung biopsy revealed a poorly differentiated
carcinoma with strong expression of cytokeratins 5/6,
CD5 and CD117 and absence of neuroendocrine markers
(CD56; chromogranin, synaptophysin), a constellation
highly specific for thymic carcinomas (Fig. 1e and f). A
lymphoepithelioma-like thymic carcinoma was ruled out
by negative EBV in situ hybridization. In addition, a
thymic carcinoma with t (15;19) translocation was likewise
ruled out by specific real-time polymerase chain reaction
(RT-PCR), which failed to demonstrate a BRD4-NUT gene
fusion product. Thus a final diagnosis of an undifferenti-
ated thymic carcinoma was established. The tumor at ini-
tial diagnosis presented in stage IVb (T4, N2 (hilar lymph
nodes), M1b (pleura, lung, choroid)) [11, 12].
Thymic carcinomas are often moderately differentiated
squamous cell carcinomas histologically resembling the
appearance of squamous cell carcinomas elsewhere in
the body, e.g. the lung [13, 14]. In our patient, one po-
tential differential diagnosis was the lymphocyte poor
EBV-associated lymphoepithelioma-like carcinoma, an
aggressive tumor with a poor prognosis [15, 16]. How-
ever, EBV association was ruled out by in situ hybridisa-
tion. Another differential diagnosis in young adults with
a rapidly progressive carcinoma is the so-called thymic
carcinoma with t (15; 19) translocation, which is associ-
ated with a fatal prognosis, including rapid local invasion
and systemic dissemination [17–20]. In our case, this
diagnosis could also be ruled out, since the BRD4-NUT
fusion gene transcript resulting from this chromosomal
translocation could not be detected. Hence, a final diag-
nosis of a high grade, poorly differentiated thymic car-
cinoma was established by exclusion of other possible
subtypes of primary thymic carcinomas.
Classical metastatic spread patterns of thymic carcin-
oma comprise regional anterior perithymic, deep intra-
thoracic and cervical lymph nodes, as well as the pleura,
the pericardium and the lung [12]. Extrathoracic organ
metastases mainly affect the liver and the kidney, but
may also involve the bones [4, 21–24]. Also one case of
orbit metastases from a neuroendocrine thymic carcin-
oma was reported [25].
To our knowledge, our patient represents the first case
of choroidal metastases from thymic carcinoma. Al-
though choroidal metastases are generally rare (e.g.
about 5-10 % in breast and lung carcinoma patients, re-
spectively [26, 27]), the choroid represents the most
common ocular site for metastatic disease (up to 88 % of
secondary ocular tumors) which is due to hematogen-
enous dissemination into abundant choroidal vascula-
ture [9, 28, 29]. The most common primary tumors
presenting with choroidal metastases are breast (40-
53 %) [9, 26, 30–32] and lung carcinoma (20-29 %)
[9, 30, 33] but may also include tumors (2-4 % each)
from the gastrointestinal tract, the kidney, the prostate
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and the skin [9, 30, 34–39], as well as carcinoid tumors of
different localisation including one reported case of a
thymic carcinoid [40]. Evidence for choroidal metastases
from other tumors has emerged in recents years. These
observations are mainly limited to single case reports
and comprise metastases from malignancies of the
thyroid [29, 41–45], the urogenital tract [46–49], the
pancreas [50, 51], salivary glands [52, 53], and the
chorion [54], as well as sarcomas [55, 56].
In our patient, fractioned radiation therapy of the or-
bits with a cumulative dose of 30 Gy (10 × 3 Gy) using
opposite, coplanar and coaxial fields in an isocentric ad-
justment with 6 MV photons was performed and re-
sulted in regression of the choroidal metastases and an
improvement of visual acuity from 20/400 to 20/40 in
the right eye and from 20/40 to 20/16 in the left eye
resulting in reconstitution of reading ability. Afterwards,
chemotherapy with Cisplatin (75 mg/m2) and Paclitaxel
(175 mg/m2) was initiated as a t (15; 19)-positive carcin-
oma was still assumed at that time. Due to the rapid
clinical response, this treatment was continued for a
total of six cycles after receiving the final pathology re-
port. After four cycles, a good partial response was ob-
served in CT scan. However, progressive disease was
evident in the staging after six cycles. The regime was
then changed to a modified PAC-scheme (Carboplatin
AUC5 instead of cisplatin because of a suspected
paclitaxel-induced peripheral polyneuropathy CTC grade
1, Doxorubicin 50 mg/m2 and Cyclophosphamide
500 mg/m2). Nevertheless, the tumor progressed further,
and the patient died of progressive disease in respiratory
insufficiency eight years after first manifestation of the
dermatomyositis and fourteen months after primary
diagnosis. The median overall survival of patients with
undifferentiated thymic carcinoma has been reported to
be about six months [57].
Fig. 1 Diagnostic evaluation. a and b Composite color fundus photographs of both eyes showing the amelanotic choroidal lesions (arrows) at
the posterior pole of the right eye (a) and predominantly nasal superior to the optic disc in the left eye (b). c and d Radiographic imaging. CT
scan of the chest (c). Note the large mediastinal mass with pleural spreading. MRI scan of the orbits (d). The arrow marks the choroidal lesion. e
and f Histological appearance of the undifferentiated thymic carcinoma (400-fold magnification). The H&E stain (e) shows compact nests of
undifferentiated epithelial cells with narrow cytoplasm without evidence of keratinization, large vesicular nuclei and high mitotic rate, separated
by broad collagen bands (immunostaining for CD5). The tumor cells show a strong expression of CD5 (f) characteristic for an undifferentiated
thymic carcinoma
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Retrospectively, the pre-existing dermatomyositis might
have represented the first symptom of an at that time clin-
ically occult tumor. The association between the epithelial
thymic carcinoma and the dermatomyositis in this case
could not be totally proven but such an association has
been reported in some cases of thymomas [58], but ap-
pears to be extremely rare in thymic carcinomas with only
two reports in the literature [59, 60].
Conclusions
Our case demonstrates that thymic carcinomas should
be included into the differential diagnosis in cases with
choroidal metastases and with dermatomyositis and no
detectable tumor, especially in young adults. To our
knowledge, this is the first case of a thymic carcinoma
with highly aggressive and fatal course and atypical clin-
ical presentation with choroidal metastases.
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